Biohaven Highlights Portfolio Progress, Positive Early Patient Data from Priority Degrader Programs and Anticipated Milestones at the 44th Annual J.P. Morgan Healthcare Conference
prnewswire.com
Want to monitor PXED?
Get notified when price crosses targets, volume spikes, or RSI hits oversold
Create free account to monitor PXEDNo company information available
No data available